QNCX
Quince Therapeutics, Inc.
-0.17 (-0.63%)27.00USD4.4K成交股數27.5M市值0.4本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-26 | 12-29 | Benatti Luca | Director | S 公開市場賣出 | 50.0K | 3.47 | 174K | 39.2K | SEC |
| 2025-12-10 | 12-12 | Thye Dirk | CEO and CMO | G 贈與 | 740K | – | – | 255K | SEC |
| 2025-12-10 | 12-12 | Thye Dirk | CEO and CMO | G 贈與 | 740K | – | – | 740K | SEC |
| 2025-12-05 | 12-08 | Hannah Brendan | CBO, COO & CCO | M 選擇權執行 | 25.3K | 0.94 | 24K | 362K | SEC |
| 2025-12-05 | 12-08 | Hannah Brendan | CBO, COO & CCO | M 選擇權執行 | 2.3K | 0.55 | 1K | 337K | SEC |
| 2025-06-18 | 06-23 | Hannah Brendan | CBO, COO & CCO | A 獲配股票 | 37.7K | 1.20 | 45K | 334K | SEC |
| 2025-06-18 | 06-23 | Thye Dirk | CEO and CMO | A 獲配股票 | 151K | 1.20 | 181K | 995K | SEC |
| 2025-06-18 | 06-23 | Ryan Charles S. | President | A 獲配股票 | 7.5K | 1.20 | 9K | 130K | SEC |
| 2024-10-23 | 12-29 | Benatti Luca | Director | J 其他 | 8.9K | – | – | 89.2K | SEC |
| 2024-08-30 | 09-03 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | P 公開市場買進 | 77.0K | 0.70 | 54K | 844K | SEC |
| 2024-08-29 | 09-03 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | P 公開市場買進 | 77.5K | 0.69 | 53K | 767K | SEC |
| 2024-08-21 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 5.0K | 0.62 | 3K | 273K | SEC |
| 2024-08-21 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 2.3K | 0.61 | 1K | 268K | SEC |
| 2024-08-21 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 23.6K | 0.63 | 15K | 297K | SEC |
| 2024-08-20 | 08-22 | Ryan Charles S. | PRESIDENT | P 公開市場買進 | 48.4K | 0.65 | 31K | 122K | SEC |
| 2024-08-20 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 2.5K | 0.61 | 2K | 262K | SEC |
| 2024-08-20 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 3.4K | 0.60 | 2K | 266K | SEC |
| 2024-08-19 | 08-21 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | P 公開市場買進 | 2.2K | 0.58 | 1K | 260K | SEC |
| 2024-06-04 | 06-05 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | M 選擇權執行 | 56.1K | 0.55 | 31K | 258K | SEC |
| 2024-01-16 | 01-17 | Thye Dirk | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 150K | 0.94 | 141K | 689K | SEC |
| 2024-01-16 | 01-17 | Thye Dirk | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 90.5K | 0.55 | 50K | 539K | SEC |
| 2023-12-14 | 12-14 | Lamond David | Director | P 公開市場買進 | 22.6K | 1.04 | 24K | 2.3M | SEC |
| 2023-12-13 | 12-14 | Lamond David | Director | P 公開市場買進 | 22.6K | 1.00 | 23K | 2.3M | SEC |
| 2023-12-12 | 12-14 | Lamond David | Director | P 公開市場買進 | 300 | 1.00 | 300.00 | 2.3M | SEC |
| 2023-12-12 | 12-14 | Lamond David | Director | P 公開市場買進 | 22.3K | 1.02 | 23K | 2.3M | SEC |
| 2023-12-07 | 12-07 | Lamond David | Director | P 公開市場買進 | 19.1K | 1.01 | 19K | 2.3M | SEC |
| 2023-12-06 | 12-07 | Lamond David | Director | P 公開市場買進 | 19.1K | 1.02 | 20K | 2.3M | SEC |
| 2023-12-05 | 12-07 | Lamond David | Director | P 公開市場買進 | 19.1K | 1.01 | 19K | 2.2M | SEC |
| 2023-12-01 | 12-01 | Lamond David | Director | P 公開市場買進 | 14.4K | 0.94 | 14K | 2.2M | SEC |
| 2023-11-30 | 12-01 | Lamond David | Director | P 公開市場買進 | 14.4K | 0.90 | 13K | 2.2M | SEC |
| 2023-11-29 | 12-01 | Lamond David | Director | P 公開市場買進 | 14.4K | 0.98 | 14K | 2.2M | SEC |
| 2023-08-31 | 08-31 | Lamond David | Director | P 公開市場買進 | 41.0K | 1.32 | 54K | 2.2M | SEC |
| 2023-08-30 | 08-31 | Lamond David | Director | P 公開市場買進 | 41.0K | 1.31 | 54K | 2.1M | SEC |
| 2023-08-17 | 08-17 | Lamond David | Director | P 公開市場買進 | 24.8K | 1.29 | 32K | 2.1M | SEC |
| 2023-08-16 | 08-17 | Lamond David | Director | P 公開市場買進 | 117K | 1.29 | 151K | 2.1M | SEC |
| 2023-08-15 | 08-17 | Lamond David | Director | P 公開市場買進 | 108K | 1.32 | 142K | 2.0M | SEC |
| 2023-08-10 | 08-11 | Thye Dirk | Chief Executive Officer | P 公開市場買進 | 88.0K | 1.26 | 111K | 449K | SEC |
| 2023-08-08 | 08-09 | Hannah Brendan | Chief Business Officer | P 公開市場買進 | 71.8K | 1.22 | 88K | 202K | SEC |
| 2023-08-08 | 08-09 | McLoughlin Margaret | Director | P 公開市場買進 | 8.0K | 1.23 | 10K | 8.0K | SEC |
| 2023-08-08 | 08-09 | Thye Dirk | Chief Executive Officer | P 公開市場買進 | 80.0K | 1.24 | 99K | 361K | SEC |
| 2023-03-06 | 03-06 | Monohon Ted | Chief Accounting Officer & VP | S 公開市場賣出 | 1.9K | 0.98 | 2K | 27.4K | SEC |
| 2022-12-05 | 12-07 | Monohon Ted | Chief Accounting Officer & VP | F 繳稅扣股 | 1.6K | 0.72 | 1K | 29.3K | SEC |
| 2022-09-06 | 09-08 | Monohon Ted | Chief Accounting Officer & VP | F 繳稅扣股 | 1.5K | 1.64 | 2K | 31.0K | SEC |
| 2022-06-06 | 06-08 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | F 繳稅扣股 | 6.7K | 2.86 | 19K | 133K | SEC |
| 2022-06-06 | 06-08 | Monohon Ted | Chief Accounting Officer & VP | F 繳稅扣股 | 1.5K | 3.12 | 5K | 32.5K | SEC |
| 2022-06-06 | 06-08 | Holsinger Leslie | EVP, Preclinical Development | F 繳稅扣股 | 10.9K | 2.86 | 31K | 148K | SEC |
| 2022-06-06 | 06-08 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | S 公開市場賣出 | 10.8K | 2.86 | 31K | 123K | SEC |
| 2022-05-19 | 05-27 | Hannah Brendan | Chief Business Officer | A 獲配股票 | 114K | – | – | 130K | SEC |
| 2022-05-19 | 05-27 | Thye Dirk | Chief Executive Officer | A 獲配股票 | 216K | – | – | 281K | SEC |
| 2022-05-19 | 05-27 | Smith Karen L. | Chief Medical Officer | A 獲配股票 | 170K | – | – | 195K | SEC |
| 2022-05-19 | 05-23 | Lamond David | Director | A 獲配股票 | 200K | – | – | 1.7M | SEC |
| 2022-05-19 | 05-23 | Hannah Brendan | Chief Business Officer | A 獲配股票 | 16.2K | – | – | 16.2K | SEC |
| 2022-05-19 | 05-23 | Thye Dirk | Chief Executive Officer | A 獲配股票 | 64.6K | – | – | 64.6K | SEC |
| 2022-05-19 | 05-23 | Smith Karen L. | Chief Medical Officer | A 獲配股票 | 24.3K | – | – | 24.3K | SEC |
| 2022-05-19 | 05-23 | Low Philip S | Director | A 獲配股票 | 64.0K | – | – | 64.0K | SEC |
| 2022-05-19 | 05-23 | Low Philip S | Director | A 獲配股票 | 455K | – | – | 455K | SEC |
| 2022-03-03 | 03-04 | LOWE CHRISTOPHER P. | Interim CEO, COO & CFO | A 獲配股票 | 175K | – | – | 265K | SEC |
| 2022-03-03 | 03-04 | Monohon Ted | Chief Accounting Officer & VP | A 獲配股票 | 34.0K | – | – | 34.0K | SEC |
| 2022-03-03 | 03-04 | Holsinger Leslie | EVP, Preclinical Development | A 獲配股票 | 156K | – | – | 159K | SEC |
| 2022-03-03 | 03-04 | Detke Michael J. | Chief Medical Officer | A 獲配股票 | 140K | – | – | 140K | SEC |
| 2022-03-03 | 03-04 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | A 獲配股票 | 140K | – | – | 140K | SEC |
| 2021-11-18 | 11-19 | Lynch Casey | Chief Executive Officer | M 選擇權執行 | 60.0K | 0.46 | 28K | 110K | SEC |
| 2021-11-16 | 11-16 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | M 選擇權執行 | 30.0K | 2.23 | 67K | 90.0K | SEC |
| 2021-11-12 | 11-12 | Dominy Stephen S. | Chief Scientific Officer | P 公開市場買進 | 763 | 14.40 | 11K | 1.2M | SEC |
| 2021-10-08 | 10-12 | McLoughlin Margaret | Director | M 選擇權執行 | 1.0K | 17.00 | 17K | 1.0K | SEC |
| 2021-10-08 | 10-12 | McLoughlin Margaret | Director | S 公開市場賣出 | 1.0K | 88.93 | 89K | 0 | SEC |
| 2021-10-05 | 10-07 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 5.0K | 98.50 | 489K | 60.0K | SEC |
| 2021-10-05 | 10-07 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | M 選擇權執行 | 5.0K | 54.85 | 272K | 65.0K | SEC |
| 2021-08-17 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | M 選擇權執行 | 30.0K | 2.23 | 67K | 60.0K | SEC |
| 2021-08-16 | 08-18 | McLoughlin Margaret | Director | S 公開市場賣出 | 423 | 97.55 | 41K | 48 | SEC |
| 2021-08-16 | 08-18 | McLoughlin Margaret | Director | S 公開市場賣出 | 1.0K | 95.57 | 100K | 1.9K | SEC |
| 2021-08-16 | 08-18 | McLoughlin Margaret | Director | S 公開市場賣出 | 3.1K | 94.55 | 289K | 2.9K | SEC |
| 2021-08-16 | 08-18 | McLoughlin Margaret | Director | M 選擇權執行 | 6.0K | 17.00 | 102K | 6.0K | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 2.1K | 98.90 | 205K | 30.0K | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 1.1K | 97.28 | 107K | 32.1K | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 2.3K | 96.32 | 224K | 33.2K | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 7.3K | 95.02 | 697K | 35.5K | SEC |
| 2021-08-16 | 08-18 | McLoughlin Margaret | Director | S 公開市場賣出 | 1.4K | 96.51 | 138K | 471 | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | S 公開市場賣出 | 9.2K | 94.23 | 863K | 42.8K | SEC |
| 2021-08-16 | 08-18 | LOWE CHRISTOPHER P. | COO & Chief Financial Officer | M 選擇權執行 | 22.0K | 2.23 | 49K | 52.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Balyasny Asset Management L.P. | 70.0K | 12.6M | 新進 | 新進 |
| Ikarian Capital, LLC | 72.3K | 1.3M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 70.8K | 1.3M | 新進 | 新進 |
| Squadron Capital Management LLC | 40.4K | 734K | 新進 | 新進 |
| Shay Capital LLC | 17.5K | 329K | 新進 | 新進 |
| BOOTHBAY FUND MANAGEMENT, LLC | 13.9K | 253K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 12.6K | 230K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.0K | 219K | 新進 | 新進 |
| Cormorant Asset Management, LP | 5.5K | 100K | 新進 | 新進 |
| UBS Group AG | 4.7K | 86K | 新進 | 新進 |
| MORGAN STANLEY | 4.1K | 74K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 3.6K | 66K | 新進 | 新進 |
| BlackRock, Inc. | 1.7K | 31K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 567 | 10K | 新進 | 新進 |
| Gen-Wealth Partners Inc | 165 | 3K | 新進 | 新進 |
| Operose Advisors LLC | 159 | 3K | 新進 | 新進 |
| Fortitude Family Office, LLC | 40 | 728.00 | 新進 | 新進 |
| BARCLAYS PLC | 27 | 491.00 | 新進 | 新進 |
| Integrated Wealth Concepts LLC | 12 | 218.00 | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 10 | 182.00 | 新進 | 新進 |
| Allworth Financial LP | 8 | 137.00 | 新進 | 新進 |
| Parallel Advisors, LLC | 3 | 55.00 | 新進 | 新進 |
| JDM Financial Group LLC | 1 | 18.00 | 新進 | 新進 |
| Westside Investment Management, Inc. | 1 | 18.00 | 新進 | 新進 |
| Steward Partners Investment Advisory, LLC | 1 | 18.00 | 新進 | 新進 |
持有機構數近 12 季
| 持有機構 · 季變化 | 27 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 27 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 330K · 32.5% |
| 合計季末市值 | 17.3M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 57.0K |
|---|---|
| 與上期比 | -5.5% |
| 佔流通股數 | 5.60% |
| 日均成交量 | 21.4K |
| 回補天數 | 2.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 57.0K | -5.5% | 5.60% | 21.4K | 2.7 |
| 2026-08-14 | 60.3K | +6.4% | 5.93% | 34.9K | 1.7 |
| 2026-07-31 | 56.6K | +12.0% | 5.57% | 37.3K | 1.5 |
| 2026-07-15 | 50.6K | -55.2% | 4.97% | 42.8K | 1.2 |
| 2026-06-30 | 113K | -94.4% | 11.09% | 23.6K | 4.8 |
| 2026-06-15 | 2.0M | -2.3% | 197.87% | 602K | 3.3 |
| 2026-05-29 | 2.1M | +17.2% | 202.52% | 3.5M | 1.0 |
| 2026-05-15 | 1.8M | -1.5% | 172.87% | 768K | 2.3 |
| 2026-04-30 | 1.8M | -8.6% | 175.50% | 1.7M | 1.1 |
| 2026-04-15 | 2.0M | -85.9% | 191.91% | 21.2M | 1.0 |
| 2026-03-31 | 13.8M | +24.0% | 1,359.46% | 27.2M | 1.0 |
| 2026-03-13 | 11.2M | +34.4% | 1,096.59% | 47.1M | 1.0 |
| 2026-02-27 | 8.3M | -19.7% | 815.90% | 41.4M | 1.0 |
| 2026-02-13 | 10.3M | +451.1% | 1,016.50% | 284M | 1.0 |
| 2026-01-30 | 1.9M | -45.7% | 184.44% | 6.8M | 1.0 |
| 2026-01-15 | 3.5M | +31.9% | 339.63% | 1.0M | 3.3 |
| 2025-12-31 | 2.6M | +26.8% | 257.40% | 501K | 5.2 |
| 2025-12-15 | 2.1M | +33.0% | 202.99% | 1.2M | 1.7 |
| 2025-11-28 | 1.6M | +13.6% | 152.60% | 1.1M | 1.4 |
| 2025-11-14 | 1.4M | +4.2% | 134.30% | 506K | 2.7 |
| 2025-10-31 | 1.3M | -0.9% | 128.95% | 210K | 6.3 |
| 2025-10-15 | 1.3M | +48.5% | 130.19% | 582K | 2.3 |
| 2025-09-30 | 891K | +2.1% | 87.65% | 264K | 3.4 |
| 2025-09-15 | 873K | -2.5% | 85.81% | 118K | 7.4 |
| 2025-08-29 | 895K | -3.7% | 87.99% | 122K | 7.4 |
| 2025-08-15 | 929K | +4.8% | 91.35% | 261K | 3.6 |